Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.
J&Js failure to win approval of an $8 billion bankruptcy plan for its talc liabilities is the latest court ruling to pare ...
A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it ...
Erythropoietin, aka EPO, is best known for its role in the Lance Armstrong cheating scandal. But EPO is also the star of ...
Johnson & Johnson announced it has completed its acquisition of Intra-Cellular Therapies. Intra-Cellular Therapies is now part of Johnson ...
A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby powder caused cancer.
One big reason the Dow Jones Industrial Average slipped Tuesday had little to do with tariffs. Johnson & Johnson's stock ...
14h
Zacks Investment Research on MSNJohnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to ConsiderJohnson & Johnson (JNJ) closed the latest trading day at $155.36, indicating a +1.38% change from the previous session's end. The stock's change was more than the S&P 500's daily gain of 0.67%. On the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results